State Key Laboratory of Drug Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
PLoS One. 2011;6(9):e25444. doi: 10.1371/journal.pone.0025444. Epub 2011 Sep 30.
Lysine-specific demethylase 1 (LSD1), the first identified histone demethylase, is a flavin-dependent amine oxidase which specifically demethylates mono- or dimethylated H3K4 and H3K9 via a redox process. It participates in a broad spectrum of biological processes and is of high importance in cell proliferation, adipogenesis, spermatogenesis, chromosome segregation and embryonic development. To date, as a potential drug target for discovering anti-tumor drugs, the medical significance of LSD1 has been greatly appreciated. However, the catalytic mechanism for the rate-limiting reductive half-reaction in demethylation remains controversial. By employing a combined computational approach including molecular modeling, molecular dynamics (MD) simulations and quantum mechanics/molecular mechanics (QM/MM) calculations, the catalytic mechanism of dimethylated H3K4 demethylation by LSD1 was characterized in details. The three-dimensional (3D) model of the complex was composed of LSD1, CoREST, and histone substrate. A 30-ns MD simulation of the model highlights the pivotal role of the conserved Tyr761 and lysine-water-flavin motif in properly orienting flavin adenine dinucleotide (FAD) with respect to substrate. The synergy of the two factors effectively stabilizes the catalytic environment and facilitated the demethylation reaction. On the basis of the reasonable consistence between simulation results and available mutagenesis data, QM/MM strategy was further employed to probe the catalytic mechanism of the reductive half-reaction in demethylation. The characteristics of the demethylation pathway determined by the potential energy surface and charge distribution analysis indicates that this reaction belongs to the direct hydride transfer mechanism. Our study provides insights into the LSD1 mechanism of reductive half-reaction in demethylation and has important implications for the discovery of regulators against LSD1 enzymes.
赖氨酸特异性脱甲基酶 1(LSD1),作为首个被鉴定的组蛋白去甲基化酶,是一种黄素依赖性胺氧化酶,通过氧化还原过程特异性地去甲基化单甲基化或二甲基化的 H3K4 和 H3K9。它参与广泛的生物学过程,在细胞增殖、脂肪生成、精子发生、染色体分离和胚胎发育中具有重要作用。迄今为止,作为发现抗肿瘤药物的潜在药物靶点,LSD1 的医学意义得到了极大的重视。然而,去甲基化过程中限速还原半反应的催化机制仍存在争议。本研究采用包括分子建模、分子动力学(MD)模拟和量子力学/分子力学(QM/MM)计算在内的综合计算方法,详细研究了 LSD1 介导的 H3K4 二甲基化去甲基化的催化机制。该模型的三维(3D)结构由 LSD1、CoREST 和组蛋白底物组成。对该模型进行了 30ns 的 MD 模拟,突出了保守的 Tyr761 和赖氨酸-水-黄素基序在正确定向黄素腺嘌呤二核苷酸(FAD)与底物方面的关键作用。这两个因素的协同作用有效地稳定了催化环境并促进了去甲基化反应。基于模拟结果与已有突变体数据之间的合理一致性,进一步采用 QM/MM 策略探究了去甲基化反应中还原半反应的催化机制。通过势能面和电荷分布分析确定的去甲基化途径的特征表明,该反应属于直接氢转移机制。本研究深入了解了 LSD1 去甲基化反应中还原半反应的机制,对 LSD1 酶抑制剂的发现具有重要意义。